At SpeculatingStocks You Can Discover Stocks, Post Anonymously, and React to Posts. Login is Optional.
Watch for Reactions to Your Posts or React Below to Other's Posts. Discover Stocks and Market Data.


October 20, 2006 Stock Pick: Genitope Corporation (GTOP)

Stock Price: $3.62

Genitope Corporation is a biotechnology company focused on the research and development of novel immunotherapies for the treatment of cancer. The company's lead product candidate, MyVax® personalized immunotherapy, is a patient-specific active immunotherapy based on the unique genetic makeup of a patient's tumor and is designed to activate the patient's immune system to identify and attack cancer cells.

GTOP is still a year away from their clinical phase III trial result for MyVax®, but GTOP's chart setup is looking sharp. There's a gap between $3.83 and $5.20 that should be covered as time progresses especially with the way GTOP has been trending higher since August.

GTOP could even fill the gap by gapping higher with 20.80% of the float short. These shorts could be forced to buy back and cause a short squeeze to add to the buying pressure.

Retail and institutional investors have both been moving into GTOP. In fact, CPMG, Inc. purchased $3.03 million in GTOP shares between $2.50 and $2.91 since August.

GTOP has $64.85 million in short-term investments on the balance sheet and cash of $10.45 million. GTOP is trading slightly above its book value of $3.50.

Untitled Document